Complement in different stages of HIV infection and pathogenesis

被引:13
作者
Speth, C
Stoiber, H
Dierich, MP
机构
[1] Univ Innsbruck, Inst Hyg & Social Med, A-6020 Innsbruck, Austria
[2] Ludwig Boltzmann Inst AIDS Res, Innsbruck, Austria
关键词
HIV; complement; co-infection; therapy;
D O I
10.1159/000070211
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The complement system is one of the most important weapons of innate immunity and is involved in all infectious processes. It is not only a mechanism for direct protection against an invading pathogen but it also interacts with the adaptive immunity to optimize the pathogenspecific humoral and cellular defence cascade in the body. One of the greatest challenges for the complement system is infection by HIV with its chronic course and sequential destruction of immune cells and immune organs. Due to its dual role as direct effector and as fine tuner of adaptive immunity, we focussed on complement in this review and analysed in detail the contribution of complement to the antiviral defence and to HIV pathogenesis on the one hand and the complement evasion strategies of the virus on the other hand. In the present review, this interplay between complement and the virus is illuminated for the three different stages of HIV pathogenesis and for events during therapy: (1) the acute infection process with the early events in mucosa and serum; (2) the asymptomatic stage with the complex interplay between complement-induced lysis and viral evasion strategies; (3) the symptomatic infection and AIDS stage with progressive destruction of the lymph nodes, opportunistic infections and development of neuropathogenesis, and (4) finally, during highly active antiretroviral therapy and in vaccination approaches. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:247 / 257
页数:11
相关论文
共 108 条
[1]   Molecular cloning and characterization of the human anaphylatoxin C3a receptor [J].
Ames, RS ;
Li, Y ;
Sarau, HM ;
Nuthulaganti, P ;
Foley, JJ ;
Ellis, C ;
Zeng, ZZ ;
Su, K ;
Jurewicz, AJ ;
Hertzberg, RP ;
Bergsma, DJ ;
Kumar, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) :20231-20234
[2]   Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system [J].
Ara, Y ;
Saito, T ;
Takagi, T ;
Hagiwara, E ;
Miyagi, Y ;
Sugiyama, M ;
Kawamoto, S ;
Ishii, N ;
Yoshida, T ;
Hanashi, D ;
Koshino, T ;
Okada, H ;
Okuda, K .
IMMUNOLOGY, 2001, 103 (01) :98-105
[3]  
BARTHOLOMEW RM, 1978, J IMMUNOL, V121, P1748
[4]   LYSIS OF ONCORNAVIRUSES BY HUMAN-SERUM - ISOLATION OF VIRAL COMPLEMENT (C1) RECEPTOR AND IDENTIFICATION AS P15E [J].
BARTHOLOMEW, RM ;
ESSER, AF ;
EBERHARD, HJM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 147 (03) :844-853
[5]   Mucosal gatekeepers: Selecting HIV viruses for early infection [J].
Bomsel, M ;
David, V .
NATURE MEDICINE, 2002, 8 (02) :114-116
[6]   Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells [J].
Bouhlal, H ;
Chomont, N ;
Haeffner-Cavaillon, N ;
Kazatchkine, MD ;
Belec, L ;
Hocini, H .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :3301-3306
[7]   In vivo protective anti-HIV immune responses in non-human primates through DNA immunization [J].
Boyer, JD ;
Wang, B ;
Ugen, KE ;
Agadjanyan, M ;
Javadian, A ;
Frost, P ;
Dang, KS ;
Carrano, RA ;
Ciccarelli, R ;
Coney, L ;
Williams, WV ;
Weiner, DB .
JOURNAL OF MEDICAL PRIMATOLOGY, 1996, 25 (03) :242-250
[8]   COMPLEMENT RECEPTOR TYPE-2 MEDIATES INFECTION OF THE HUMAN CD4-NEGATIVE RAJI B-CELL LINE WITH OPSONIZED HIV [J].
BOYER, V ;
DELIBRIAS, C ;
NORAZ, N ;
FISCHER, E ;
KAZATCHKINE, MD ;
DESGRANGES, C .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1992, 36 (06) :879-883
[9]   COMPLEMENT MEDIATES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF A HUMAN T-CELL LINE IN A CD4-INDEPENDENT AND ANTIBODY-INDEPENDENT FASHION [J].
BOYER, V ;
DESGRANGES, C ;
TRABAUD, MA ;
FISCHER, E ;
KAZATCHKINE, MD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) :1151-1158
[10]   Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis [J].
Brack-Werner, R .
AIDS, 1999, 13 (01) :1-22